The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Investigating The Iron Proteome In Alzheimer’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$514,644.00
Summary
Iron is essential for brain function. When the delicate balance of metals in the brain is disturbed, neurodegenerative effects such as those seen in Alzheimer’s disease are observed. Although we know there is a link between iron and Alzheimer’s disease, we do not know which specific iron proteins are involved. This project will provide the first characterisation of different iron proteins in the brain to understand the mechanisms of disease and help in the search for new treatments.
Determining The Clinical Effectiveness Of Antiviral Drugs Against Oseltamivir- And Laninamivir-resistant Influenza Viruses In Animal Models
Funder
National Health and Medical Research Council
Funding Amount
$388,067.00
Summary
Currently, the neuraminidase inhibitors are the only drugs that are effective against seasonal influenza viruses. However, viruses can develop resistance to these drugs. Using viruses with varied levels of resistance, the project will determine the effectiveness of different drug treatments in animal models. This will lead to better treatment for those patients seriously ill with drug-resistant influenza viruses.
Parasitic infections are a significant global health problem, resulting in more than a million deaths annually. Unfortunately there is no licensed vaccine available for any human parasitic infection, and in many cases current drugs suffer from issues of parasite drug resistance. To address this problem this project brings together leading researchers from the European Union, Brazil, and Australia to discover and develop new types of drugs for four major human parasitic diseases: schistosomiasis, ....Parasitic infections are a significant global health problem, resulting in more than a million deaths annually. Unfortunately there is no licensed vaccine available for any human parasitic infection, and in many cases current drugs suffer from issues of parasite drug resistance. To address this problem this project brings together leading researchers from the European Union, Brazil, and Australia to discover and develop new types of drugs for four major human parasitic diseases: schistosomiasis, leishmaniasis, Chagas disease and malaria.Read moreRead less
New Strategies In The Treatment And Imaging Of Neurodegenerative Diseases
Funder
National Health and Medical Research Council
Funding Amount
$934,085.00
Summary
The treatment and diagnosis of brain diseases is one of society’s major challenges. To address these challenges, we need a better understanding of the molecular mechanisms involved in brain disease. We will develop innovative ways in which to probe disease progression, assess efficacy of treatment, and ultimately treat a wide range of brain disorders.
Can Music Mend Minds? Investigating The Mechanisms Underlying The Beneficial Effects Of Music On Persons With Dementia
Funder
National Health and Medical Research Council
Funding Amount
$411,108.00
Summary
Music can have positive effects on persons with dementia. It be a powerful trigger of memories and emotions and provide a link to one's personal past and a form of communication with carers. Familiar songs can be recognised even in the late stages of dementia when verbal communication and memory for other things may be lost. There has been little scientific investigation of how and why music can help people with dementia and their carers. This research will address this issue.
Sleep, Plasticity And Neurodegeneration: Targeting Sleep To Improve Cognition In Mild Cognitive Impairment (MCI)
Funder
National Health and Medical Research Council
Funding Amount
$525,116.00
Summary
Older individuals with mild cognitive impairment commonly experience disturbed sleep and about 50% will convert to dementia. It is unclear whether sleep disturbance mediates cognitive decline and progression to dementia. Optimising sleep presents a novel strategy to slow disease progression. This new research program explores links between sleep and dementia to identify new biomarkers of disease progression and new targeted therapeutic approaches to improve quality of life for older Australians.
Predicting Perioperative Cognitive Disorders In The Elderly Based On Cardiovascular Risk, AD Risk And New Biomarkers
Funder
National Health and Medical Research Council
Funding Amount
$471,826.00
Summary
Anaesthesia and surgery are common in the elderly and are known to lead to memory and thinking problems. Why this happens is unclear. I plan to study confusion, memory and thinking problems before and after surgery and to determine if blood or cerebrospinal fluid tests or modifying cardiovascular disease can predict this happening. This work will lead to early identification of people who are at risk of cognitive problems following anaesthesia and surgery, and ways to prevent this happening.
What Can Tau Deposition Tell Us About The Appearance Of Subjective And Objective Cognitive Decline In Older Adults?
Funder
National Health and Medical Research Council
Funding Amount
$674,077.00
Summary
Subjective memory concerns are common in older adults, but it is uncertain how they relate to Alzheimer’s disease (AD) biomarkers. Novel neuroimaging techniques have been developed for measuring tau deposition, a hallmark feature of AD. Using this technique, I aim to determine whether tau is sensitive to certain types of subjective concerns. My findings will reveal which concerns are indicative of AD risk, and which arise from unrelated factors, such as inattention or stress.
Dementia is an urgent global challenge with enormous health and economic cost to Australia. While the hope is for a cure, the number with dementia is growing and diagnosis is often delayed by ~3 years. This project will use innovative neurocognitive methods to achieve earlier diagnosis and develop tailored treatments. This will enhance or maintain function, promoting independence and community living, improving the quality of life and care for persons living with dementia.
We need to think laterally to find effective treatments for people with dementia. Using relevant animal models and cutting-edge technology, my research investigates gene-environment interactions. In particular, my group is studying the pathophysiology of Huntington’s disease, a devastating progressive disorder with no current cure. By integrating my unique wide-ranging expertise and my extensive network of collaborators, I aim to explore mechanisms and to discover novel therapeutic strategies.